CellSeed Inc. is mainly engaged in the regenerative medical business. The Company operates in two business segments. The Regenerative Medical Support segment is engaged in the research, development, manufacture and sale of temperature-responsive cell incubators. The Cell Sheet Regeneration Medical segment is involved in the research and development of cell sheet regenerative medical products.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-08-28	JP¥236.00	+2.16%	193,500
26-08-27	JP¥231.00	-1.28%	82,500
26-08-26	JP¥234.00	+0.43%	95,200
26-08-25	JP¥233.00	+0.43%	137,600
26-08-24	JP¥232.00	-0.43%	162,700

Delayed Quote Japan Exchange

More quotes

Market Closed - Japan Exchange 02:30:00 2026-08-28 EDT			5-day change	1st Jan Change
236.00 ^JPY	+2.16%		+1.29%	-8.88%

12-07	CellSeed Inc. announced that it has received ¥3.44 million in funding from Barclays Bank PLC, Investment Arm	CI
11-20	CellSeed Inc. announced that it expects to receive ¥3.44 million in funding from Barclays Bank PLC, Investment Arm	CI

Market Cap	4.1B 25.64M 22.1M 20.72M 18.91M 35.63M 2.45B 35.74M 246M 95.91M 1.24B 96.28M 94.19M	P/E 2020	-4.47x	P/E 2021	-3.46x
Enterprise Value	3.33B 20.83M 17.95M 16.83M 15.36M 28.93M 1.99B 29.03M 200M 77.88M 1B 78.19M 76.49M	EV / Sales 2020	12.4x	EV / Sales 2021	15.5x
Free-Float	98.55%	Yield 2020 *	-	Yield 2021	-

12-07	CellSeed Inc. announced that it has received ¥3.44 million in funding from Barclays Bank PLC, Investment Arm	CI
11-20	CellSeed Inc. announced that it expects to receive ¥3.44 million in funding from Barclays Bank PLC, Investment Arm	CI
24-09-22	CellSeed Inc.(TSE:7776) added to S&P Global BMI Index	CI
23-06-04	CellSeed Inc. announced that it has received ¥2.001 million in funding from Barclays Bank PLC, Investment Arm	CI
23-05-14	CellSeed Inc. announced that it expects to receive Â¥2.001 million in funding from Barclays Bank PLC, Investment Arm	CI
22-01-04	CellSeed Inc. announced that it has received ¥1.144 million in funding from Barclays Bank PLC, Investment Arm	CI
21-12-19	CellSeed Inc. announced that it expects to receive ¥1.144 million in funding from Barclays Bank PLC, Investment Arm	CI
20-08-05	CellSeed Inc. announced that it has received ¥3.78 million in funding from Barclays Bank PLC, Investment Arm	CI
20-07-20	CellSeed Inc. announced that it expects to receive ¥3.78 million in funding from Barclays Bank PLC, Investment Arm	CI
19-09-01	CellSeed Inc. announced that it has received ¥2.884 million in funding	CI
19-08-13	An unknown buyer acquired 0.34% stake in CellSeed Inc. from Emmaus Life Sciences, Inc. for $0.22 million.	CI
19-08-13	CellSeed Inc. announced that it expects to receive ¥2.884 million in funding	CI
17-03-05	CellSeed Inc. announced that it has received ¥6.6 million in funding from Evolution Capital Management, LLC	CI

1 day	+2.16%
1 week	+1.29%
Current month	+7.76%
1 month	+14.56%
3 months	-5.98%
6 months	-36.22%
Current year	-8.88%

CellSeed Inc. Stock

Stocks

7776

JP3423530009

Pharmaceuticals

Valuation : CellSeed Inc.

Chart: CellSeed Inc.

Latest news : CellSeed Inc.

Quotes and Performance

Price Extremes

Managers and Directors : CellSeed Inc.

Biopharmaceuticals

Financials

Company Profile

Quotes

Manager	Title	Age	Since
Setsuko Hashimoto PSD	President	73	2014-05-31
Keiichiro Nakaoka IRC	Investor Relations Contact	50	2019-09-30
Toshihiro Maeda PRN	Corporate Officer/Principal	70	2017-09-30

Director	Title	Age	Since
Setsuko Hashimoto BRD	Director/Board Member	73	2014-02-28
Kenji Oeda BRD	Director/Board Member	74	2017-02-28
Sachiko Endo BRD	Director/Board Member	72	2023-02-28

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CELLSEED INC.	+2.16%	+1.29%	-46.49%	-8.17%	57.17M
REGENERON PHARMACEUTICALS, INC.	-1.67%	-4.78%	+37.02%	-4.42%	80.65B
CSL LIMITED	-0.90%	+2.39%	-18.98%	-35.69%	59.9B
MODERNA, INC.	-3.35%	-4.92%	+463.91%	+21.22%	57B
SAMSUNG BIOLOGICS CO.,LTD.	-6.78%	-4.19%	-4.50%	+28.86%	53.35B
UCB	-2.43%	-2.35%	+8.03%	+163.45%	49.29B
BIOGEN INC.	-1.35%	+0.79%	+64.72%	-17.56%	32.73B
INCYTE CORPORATION	-2.64%	-2.69%	+48.59%	+91.84%	25.89B
INNOVENT BIOLOGICS, INC.	-0.09%	+4.98%	+18.59%	+209.35%	23.9B
SWEDISH ORPHAN BIOVITRUM AB	-0.34%	+1.35%	+60.10%	+122.64%	17.07B
Average	-1.43%	-0.94%	+63.10%	+57.15%	39.98B
Weighted average by Cap.	-2.01%	-1.92%	+83.26%	+43.04%

	2020	2021
Net sales	199M 1.24M 1.07M 1.01M 917K 1.73M 119M 1.73M 11.92M 4.65M 60.02M 4.67M 4.57M	161M 1.01M 867K 813K 742K 1.4M 96.19M 1.4M 9.65M 3.76M 48.55M 3.78M 3.7M
Net income	-783M -4.89M -4.22M -3.95M -3.61M -6.8M -468M -6.82M -46.92M -18.31M -236M -18.38M -17.98M	-914M -5.71M -4.92M -4.62M -4.21M -7.94M -546M -7.96M -54.77M -21.37M -276M -21.45M -20.98M
Net Debt	-1.3B -8.13M -7M -6.57M -5.99M -11.29M -777M -11.33M -77.89M -30.39M -392M -30.51M -29.85M	-771M -4.82M -4.15M -3.89M -3.55M -6.7M -461M -6.72M -46.2M -18.02M -233M -18.1M -17.7M

1 week	227	239
1 month	201	242
Current year	200	416
1 year	200	518
3 years	200	1,160
5 years	122	1,160
10 years	122	2,020